Purchased shares and warrants under the April 2025 PIPE financing
| Officer | Age | In this role | Joined | Source |
|---|---|---|---|---|
|
Daniel Tassé
Also a director
Chief Executive Officer and Director
|
66 | Not stated | Not stated | |
|
Virginie Boucinha
Chief Financial Officer
|
56 |
Since 2023
3 years
|
Not stated | |
|
Pharis Mohideen
Chief Medical Officer
|
61 |
Since 2019
7 years
|
Not stated | |
|
Kevin Trapp
Chief Commercial Officer
|
59 | Not stated | 2025 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Purchased shares and warrants under the April 2025 PIPE financing
Purchased shares and warrants under the April 2025 PIPE financing
Registration rights agreement granting Baker Brothers demand and piggyback registration rights
2025 registration rights agreement covering resale of PIPE financing shares and warrant shares
Executive agreement providing annual base salary, bonus and severance terms
Employment agreement providing annual base salary, bonus and severance terms
Employment agreement providing annual base salary, bonus and severance terms
Employment agreement providing annual base salary, bonus and severance terms
Loading...